Patent details

EP1814573 Title: REMODELING AND GLYCOPEGYLATION OF FIBROBLAST GROWTH FACTOR (FGF)

Basic Information

Publication number:
EP1814573
PCT Application Number:
PCT/US/2005/039226
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058247230
PCT Publication Number:
WO/2006/050247
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
REMODELING AND GLYCOPEGYLATION OF FIBROBLAST GROWTH FACTOR (FGF)
French Title of Invention:
REMODELAGE ET GLYCOPEGYLATION DU FACTEUR DE CROISSANCE DES FIBROBLASTES (FGF)
German Title of Invention:
REMODELLIERUNG UND GLYKOPEGYLIERUNG VON FIBROBLASTEN-WACHSTUMSFAKTOR (FGF)
SPC Number:

Dates

Filing date:
31/10/2005
Grant date:
09/03/2016
EP Publication Date:
09/03/2016
PCT Publication Date:
11/05/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/08/2007
EP B1 Publication Date:
09/03/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
31/10/2016
Expiration date:
31/10/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/10/2005
 
 

Name:
ratiopharm GmbH
Address:
Graf-Arco-Strasse 3, 89079 Ulm, Germany (DE)

Inventor

Name:
DEFREES Shawn
Address:
United States (US)

Priority

Priority Number:
623342 P
Priority Date:
29/10/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/16;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages